Ticker · CUSIP 478160104

JNJ

JOHNSON & JOHNSON
Healthcare·Drug Manufacturers - General
···Share
Holders (tracked)
30
Combined shares
104,281,533
Combined value
$21.58B
Last close
$234.18
Quarter
2025Q4
Price · 1Y$234.18+76.71 (+48.71%)H $248.56 · L $146.36 · Avg Vol 8.5M
Analyst target$242.17EarningsCongress buyCongress sellPosition opened
$150.00$200.00$250.00Target $242.17VolJul 25Oct 25Jan 26Apr 26
See full analyst target history →
Tracked holders · last 8 quarters
+3 vs previous quarter over the last 8.
30252024Q12025Q4
Price is +13.2% vs the avg quarter-end implied price across tracked holders.
About

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

CEO
Joaquin Duato
Employees
138,100
Exchange
NYSE
Country
US
IPO
1943-01-02
Website
www.jnj.com
Key statistics
52W range83% of range
$146.12$251.71
Market cap
$564.35B
Enterprise value
$592.57B
Shares out
—
Beta
0.33
P/E (TTM)
27.22
Div yield
2.22%
52W high
$251.71
52W low
$146.12
50D avg
$241.32
200D avg
$202.34
Volume
8.83M
Avg volume
—

Valuation & profitability

TTM · FMP
Multiples
P/E (TTM)
27.22
PEG
-1.24
P/S
5.86
P/B
7.02
P/FCF
28.65
EV/Sales
6.15
EV/EBITDA
19.34
EV/FCF
30.08
Earnings yield
3.7%
FCF yield
3.5%
Profitability
Gross margin
73.9%
EBITDA margin
31.8%
Operating margin
26.7%
Net margin
21.8%
Returns & leverage
ROE
26.5%
ROA
10.6%
ROIC
14.1%
Debt / equity
0.59
Current ratio
1.03
Quarterly financials
Last 5Q
Revenue
$24.06B2026 Q1
2025Q12026Q1
Net income
$5.24B2026 Q1
2025Q12026Q1
Operating income
$6.39B2026 Q1
2025Q12026Q1
EPS (diluted)
$2.142026 Q1
2025Q12026Q1
Earnings surprise
EPS · Last 4Q
FY26 Q2 actual$2.70vs est $2.68+0.7%
EstimateActual (beat)Actual (miss)
+3.4%FY25 Q3+1.4%FY25 Q4+0.0%FY26 Q1+0.7%FY26 Q2

Revenue segmentation

FMP · annual
By product line
FY2025$94.19B total
  • Innovative Medicine$60.40B · 64.1%
  • MedTech$33.79B · 35.9%
By geography
FY2025$94.19B total
  • UNITED STATES$53.75B · 57.1%
  • Europe$21.54B · 22.9%
  • Asia-Pacific, Africa$14.03B · 14.9%
  • Western Hemisphere, excluding U.S.$4.88B · 5.2%

SEC event timeline

30 events
  1. AQR Capital Management trimmed2026-02-17
    −450,231 shares · 2025Q4
    Position
  2. Ken Griffin (Citadel Advisors) trimmed2026-02-17
    −545,257 shares · 2025Q4
    Position
  3. D.E. Shaw & Co. trimmed2026-02-17
    −260,159 shares · 2025Q4
    Position
  4. Wellington Management trimmed2026-02-17
    −2,594,389 shares · 2025Q4
    Position
  5. Paul Tudor Jones (Tudor Investment) opened position2026-02-17
    +527,700 shares · 2025Q4
    Position
  6. Ron Baron (Baron Capital / BAMCO) opened position2026-02-17
    +3,600 shares · 2025Q4
    Position
  7. Jeremy Grantham (GMO) added2026-02-17
    +273,944 shares · 2025Q4
    Position
  8. Two Sigma Investments trimmed2026-02-17
    −894,928 shares · 2025Q4
    Position
  9. Izzy Englander (Millennium Mgmt) added2026-02-17
    +299,951 shares · 2025Q4
    Position
  10. Steve Cohen (Point72) added2026-02-17
    +113,215 shares · 2025Q4
    Position
  11. T. Rowe Price added2026-02-17
    +3,655,754 shares · 2025Q4
    Position
  12. John Rogers (Ariel Investments) trimmed2026-02-13
    −8,594 shares · 2025Q4
    Position
  13. Ray Dalio (Bridgewater Associates) trimmed2026-02-13
    −401,819 shares · 2025Q4
    Position
  14. Renaissance Technologies exited2026-02-12
    −306,747 shares · 2025Q4
    Position
  15. Norges Bank (Norway SWF) opened position2026-02-10
    +33,459,884 shares · 2025Q4
    Position
  16. Ken Fisher (Fisher Asset Mgmt) added2026-02-09
    +419,799 shares · 2025Q4
    Position
  17. Mario Gabelli (GAMCO) trimmed2026-02-05
    −609 shares · 2025Q4
    Position
  18. Izzy Englander (Millennium Mgmt) trimmed2025-11-14
    −424,060 shares · 2025Q3
    Position
  19. Steve Cohen (Point72) trimmed2025-11-14
    −576,374 shares · 2025Q3
    Position
  20. Two Sigma Investments added2025-11-14
    +748,295 shares · 2025Q3
    Position
  21. D.E. Shaw & Co. trimmed2025-11-14
    −1,702,136 shares · 2025Q3
    Position
  22. AQR Capital Management trimmed2025-11-14
    −469,037 shares · 2025Q3
    Position
  23. T. Rowe Price added2025-11-14
    +390,599 shares · 2025Q3
    Position
  24. Wellington Management added2025-11-14
    +956,239 shares · 2025Q3
    Position
  25. John Rogers (Ariel Investments) added2025-11-14
    +20,691 shares · 2025Q3
    Position
  26. Norges Bank (Norway SWF) exited2025-11-13
    −31,929,124 shares · 2025Q3
    Position
  27. Jeremy Grantham (GMO) added2025-11-13
    +260,764 shares · 2025Q3
    Position
  28. Ray Dalio (Bridgewater Associates) trimmed2025-11-13
    −566,762 shares · 2025Q3
    Position
  29. Renaissance Technologies trimmed2025-11-13
    −576,443 shares · 2025Q3
    Position
  30. Mario Gabelli (GAMCO) trimmed2025-11-12
    −4,207 shares · 2025Q3
    Position

Insider activity

No insider transactions in the last 30 days.
View full insider history for JNJ →
Follow-the-investor returns
If you'd copied each holder of JNJ…
Cost basis inferred from each manager's quarter-over-quarter position changes. Sorted by % return on the position they're still holding.
InvestorFirst inCost basisReturnPosition value today
Tom Gayner (Markel Group)2016Q1$108.20+116.4%$143.0M
Dodge & Cox2016Q1$109.94+113.0%$4.9M
Prem Watsa (Fairfax Financial)2016Q1$111.37+110.3%$17.2M
Wellington Management2016Q1$129.02+81.5%$5.44B
Mario Gabelli (GAMCO)2016Q1$134.69+73.9%$19.1M
AQR Capital Management2016Q1$148.81+57.4%$907.7M
Jeremy Grantham (GMO)2016Q1$149.78+56.4%$1.66B
John Rogers (Ariel Investments)2016Q1$150.26+55.8%$10.1M
Ray Dalio (Bridgewater Associates)2016Q2$154.02+52.0%$307.7M
Ken Fisher (Fisher Asset Mgmt)2016Q1$167.21+40.1%$2.08B
T. Rowe Price2016Q1$168.95+38.6%$2.91B
Paul Tudor Jones (Tudor Investment)2016Q1$170.70+37.2%$24.3M
Paul Tudor Jones (Tudor Investment)2016Q1$170.70+37.2%$24.3M
Izzy Englander (Millennium Mgmt)2016Q1$180.18+30.0%$166.8M
Izzy Englander (Millennium Mgmt)2016Q1$180.18+30.0%$166.8M
Izzy Englander (Millennium Mgmt)2016Q1$180.18+30.0%$166.8M
Two Sigma Investments2016Q1$188.16+24.5%$8.9M
Two Sigma Investments2016Q1$188.16+24.5%$8.9M
Two Sigma Investments2016Q1$188.16+24.5%$8.9M
D.E. Shaw & Co.2016Q1$191.85+22.1%$10.7M
D.E. Shaw & Co.2016Q1$191.85+22.1%$10.7M
D.E. Shaw & Co.2016Q1$191.85+22.1%$10.7M
Ken Griffin (Citadel Advisors)2016Q1$197.88+18.3%$601.8M
Ken Griffin (Citadel Advisors)2016Q1$197.88+18.3%$601.8M
Ken Griffin (Citadel Advisors)2016Q1$197.88+18.3%$601.8M
Steve Cohen (Point72)2016Q4$206.22+13.6%$43.0M
Steve Cohen (Point72)2016Q4$206.22+13.6%$43.0M
Steve Cohen (Point72)2016Q4$206.22+13.6%$43.0M
Ron Baron (Baron Capital / BAMCO)2025Q4$206.95+13.2%$843K
Norges Bank (Norway SWF)2016Q1$527.36-55.6%$7.84B

Who moved on this name in 2025Q4

Position changes reported for the latest quarter, grouped by direction.
New positions3
Added to5
Trimmed8
Exited1

Institutional ownership over time

Distinct super-investors holding this ticker · combined dollar value, by quarter.
QuarterHoldersCombined value
2022Q1
28
$4.39T
2022Q2
32
$4.28T
2022Q3
31
$50.69B
2022Q4
30
$55.43B
2023Q1
32
$49.30B
2023Q2
30
$51.42B
2023Q3
30
$40.40B
2023Q4
25
$40.55B
2024Q1
25
$46.39B
2024Q2
29
$45.28B
2024Q3
25
$17.26B
2024Q4
28
$11.44B
2025Q1
26
$11.36B
2025Q2
28
$15.69B
2025Q3
27
$13.01B
2025Q4
30
$21.58B
Congress members trading this stock
DateMemberTypeAmount rangeFiling
2026-03-26Thomas H. KeanSell (P)$1K – $15KPDF ↗
2026-03-19John BoozmanSell (P)$1K – $15KPDF ↗
2026-03-19Richard Dean Dr McCormickSell (P)$1K – $15KPDF ↗
2026-03-19Richard Dean Dr McCormickSell (P)$1K – $15KPDF ↗
2026-03-10Lloyd DoggettBuy$1K – $15KPDF ↗
2025-12-18Julie JohnsonSell$1K – $15KPDF ↗
2025-12-09Lloyd DoggettBuy$1K – $15KPDF ↗
2025-11-13Julie JohnsonSell (P)$1K – $15KPDF ↗
2025-11-05Richard Dean Dr McCormickBuy$1K – $15KPDF ↗
2025-10-31Lisa McClainSell$1K – $15KPDF ↗
2025-10-30Lisa McClainBuy$1K – $15KPDF ↗
2025-10-30Lisa McClainSell$1K – $15KPDF ↗

Who owns JNJ

30 super-investors · 2025Q4
Tracked stake
104.28M
shares
Combined value
$21.58B
% of shares outstanding
4.33%
tracked institutions only
Quarter action mix
New4Added9Trim14Held3
#ManagerSharesValue
1Norges Bank
Norway SWF
33.46M$6.92B
2Wellington Management23.24M$4.81B
3T. Rowe Price12.42M$2.57B
4Ken Fisher
Fisher Asset Mgmt
8.87M$1.83B
5Jeremy Grantham
GMO
7.09M$1.47B
6AQR Capital Management3.88M$802M
7Ken Griffin
Citadel Advisors
3.07M$636M
8Ken Griffin
Citadel Advisors
2.57M$532M
9Izzy Englander
Millennium Mgmt
1.56M$322M
10Ray Dalio
Bridgewater Associates
1.31M$272M
11Izzy Englander
Millennium Mgmt
928.6K$192M
12Steve Cohen
Point72
897.6K$186M
13D.E. Shaw & Co.883.5K$183M
14D.E. Shaw & Co.799.6K$165M
15Ken Griffin
Citadel Advisors
784.9K$162M
16Izzy Englander
Millennium Mgmt
712.4K$147M
17Tom Gayner
Markel Group
610.8K$126M
18Paul Tudor Jones
Tudor Investment
424.1K$88M
19Steve Cohen
Point72
183.7K$38M
20Steve Cohen
Point72
120.6K$25M
21Paul Tudor Jones
Tudor Investment
103.6K$21M
22Mario Gabelli
GAMCO
81.8K$17M
23Prem Watsa
Fairfax Financial
73.4K$15M
24D.E. Shaw & Co.45.7K$9M
25John Rogers
Ariel Investments
43.3K$9M
26Two Sigma Investments38.1K$8M
27Two Sigma Investments30.4K$6M
28Two Sigma Investments27.2K$6M
29Dodge & Cox20.9K$4M
30Ron Baron
Baron Capital / BAMCO
3.6K$745K

Recent moves

20 transactions
Embed this chart
Paste this iframe anywhere to embed the live JNJ chart.
<iframe src="https://openstocks.me/embed/stocks/JNJ" width="100%" height="480" frameborder="0" loading="lazy" title="JNJ chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>
Preview: https://openstocks.me/embed/stocks/JNJ
Explore related topics